257 related articles for article (PubMed ID: 12602592)
1. Antagonism of adenosine receptors by caffeine and caffeine metabolites in equine forebrain tissues.
Chou CC; Vickroy TW
Am J Vet Res; 2003 Feb; 64(2):216-24. PubMed ID: 12602592
[TBL] [Abstract][Full Text] [Related]
2. A1 and A2A adenosine receptors and A1 mRNA in mouse brain: effect of long-term caffeine treatment.
Johansson B; Georgiev V; Lindström K; Fredholm BB
Brain Res; 1997 Jul; 762(1-2):153-64. PubMed ID: 9262169
[TBL] [Abstract][Full Text] [Related]
3. Chronic effects of xanthines on levels of central receptors in mice.
Shi D; Daly JW
Cell Mol Neurobiol; 1999 Dec; 19(6):719-32. PubMed ID: 10456233
[TBL] [Abstract][Full Text] [Related]
4. Selective detection of adenosine A1 receptor-dependent G-protein activity in basal and stimulated conditions of rat brain [35S]guanosine 5'-(gamma-thio)triphosphate autoradiography.
Laitinen JT
Neuroscience; 1999; 90(4):1265-79. PubMed ID: 10338296
[TBL] [Abstract][Full Text] [Related]
5. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.
Cunha RA; Johansson B; Constantino MD; Sebastião AM; Fredholm BB
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):261-71. PubMed ID: 8692280
[TBL] [Abstract][Full Text] [Related]
6. Further characterization of [3H]-CGS 21680 binding sites in the rat striatum and cortex.
Kirk IP; Richardson PJ
Br J Pharmacol; 1995 Jan; 114(2):537-43. PubMed ID: 7881753
[TBL] [Abstract][Full Text] [Related]
7. Modification of A1 and A2a adenosine receptor binding in aged striatum, hippocampus and cortex of the rat.
Cunha RA; Constantino MC; Sebastião AM; Ribeiro JA
Neuroreport; 1995 Jul; 6(11):1583-8. PubMed ID: 7579154
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A1 receptor down-regulation in mothers and fetal brain after caffeine and theophylline treatments to pregnant rats.
León D; Albasanz JL; Ruíz MA; Fernández M; Martín M
J Neurochem; 2002 Aug; 82(3):625-34. PubMed ID: 12153486
[TBL] [Abstract][Full Text] [Related]
9. Autoradiographic comparison of the potency of several structurally unrelated adenosine receptor antagonists at adenosine A1 and A(2A) receptors.
Fredholm BB; Lindström K
Eur J Pharmacol; 1999 Sep; 380(2-3):197-202. PubMed ID: 10513579
[TBL] [Abstract][Full Text] [Related]
10. Pyrazolopyridine derivatives act as competitive antagonists of brain adenosine A1 receptors: [35S]GTPgammaS binding studies.
Ito H; Maemoto T; Akahane A; Butcher SP; Olverman HJ; Finlayson K
Eur J Pharmacol; 1999 Jan; 365(2-3):309-15. PubMed ID: 9988116
[TBL] [Abstract][Full Text] [Related]
11. Caffeine-mediated induction of c-fos, zif-268 and arc expression through A1 receptors in the striatum: different interactions with the dopaminergic system.
Dassesse D; Vanderwinden JM; Goldberg I; Vanderhaeghen JJ; Schiffmann SN
Eur J Neurosci; 1999 Sep; 11(9):3101-14. PubMed ID: 10510174
[TBL] [Abstract][Full Text] [Related]
12. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
[TBL] [Abstract][Full Text] [Related]
13. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
Alexander SP; Curtis AR; Kendall DA; Hill SJ
Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
[TBL] [Abstract][Full Text] [Related]
14. Caffeine exposure alters adenosine system and neurochemical markers during retinal development.
Brito R; Pereira-Figueiredo D; Socodato R; Paes-de-Carvalho R; Calaza KC
J Neurochem; 2016 Aug; 138(4):557-70. PubMed ID: 27221759
[TBL] [Abstract][Full Text] [Related]
15. KW-3902, a selective high affinity antagonist for adenosine A1 receptors.
Nonaka H; Ichimura M; Takeda M; Kanda T; Shimada J; Suzuki F; Kase H
Br J Pharmacol; 1996 Apr; 117(8):1645-52. PubMed ID: 8732272
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological interactions between magnesium ion and adenosine on monoaminergic system in the central nervous system.
Okada M; Kaneko S
Magnes Res; 1998 Dec; 11(4):289-305. PubMed ID: 9884987
[TBL] [Abstract][Full Text] [Related]
17. 5'-O-alkyl ethers of N,2-substituted adenosine derivatives: partial agonists for the adenosine A1 and A3 receptors.
van Tilburg EW; van der Klein PA; von Frijtag Drabbe Künzel J; de Groote M; Stannek C; Lorenzen A; IJzerman AP
J Med Chem; 2001 Aug; 44(18):2966-75. PubMed ID: 11520205
[TBL] [Abstract][Full Text] [Related]
18. 2-substituted thioadenine nucleoside and nucleotide analogues: synthesis and receptor subtype binding affinities (1).
Hasan A; Hussain T; Mustafa SJ; Srivastava PC
Bioconjug Chem; 1994; 5(4):364-9. PubMed ID: 7948104
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic administration of adenosine antagonists on adenosine A1 and A2a receptors in mouse brain.
Traversa U; Rosati AM; Florio C; Vertua R
In Vivo; 1994; 8(6):1073-8. PubMed ID: 7772740
[TBL] [Abstract][Full Text] [Related]
20. G protein coupling of CGS 21680 binding sites in the rat hippocampus and cortex is different from that of adenosine A1 and striatal A2A receptors.
Cunha RA; Constantino MD; Ribeiro JA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):295-302. PubMed ID: 10344528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
